In the same way, proliferation study has acquired great value with the new molecular classification of breast tumors, and some authors consider necessary to change the guidelines and to include Ki-67 in the standard pathological assessment of early breast cancer [22]. This evidence concerns the gene MKI67 and breast neoplasm.